Sign in

CIK 0001850119

  • Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
842040295
Phone
+1 215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,212
in 5 filings

Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Cowan Chad Chief Scientific Officer Shares withheld for taxes −358 $2.24 $802 1,175,322
2026-04-01 Cowan Chad Chief Scientific Officer Shares withheld for taxes −1,365 $2.19 $3K 1,175,680
2026-03-11 Cowan Chad Chief Scientific Officer Shares withheld for taxes −1,431 $2.73 $4K 1,177,045
2026-02-02 Cowan Chad Chief Scientific Officer Grant or award +135,000 1,178,476
2026-02-02 Cowan Chad Chief Scientific Officer Grant or award · Stock Option (right to buy) +265,000 265,000
2026-01-02 Cowan Chad Chief Scientific Officer Shares withheld for taxes −1,611 $1.00 $2K 1,043,476
2025-12-22 Cowan Chad Chief Scientific Officer Purchase +58,060 $0.85 $49K 1,045,087
2025-11-20 Cowan Chad Chief Scientific Officer Sale −5,462 $0.50 $3K 987,027
2025-09-18 Cowan Chad Chief Scientific Officer Grant or award +762,543 992,489
2025-03-11 Cowan Chad Chief Scientific Officer Grant or award +19,500 230,306
2025-03-11 Cowan Chad Chief Scientific Officer Grant or award · Stock Option (right to buy) +19,500 19,500
2024-10-01 Cowan Chad Chief Scientific Officer Grant or award +74,376 210,806
2024-10-01 Cowan Chad Chief Scientific Officer Grant or award · Stock Option (right to buy) +446,250 446,250

Page 1 of 1 · 13 trades